Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO is Breaking Out -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (845)	3/7/2000 9:02:00 AM
From: Carole	Read Replies (1) \| Respond to of 1018

Tuesday March 7, 7:59 am Eastern Time Company Press Release I-Flow Corp. InfuSystem Subsidiary Approved To Provide Infusion Pump Management Services Nationwide To US Oncology Inc. LAKE FOREST, Calif.--(BUSINESS WIRE)--March 7, 2000--I-Flow Corp. (Nasdaq:IFLO - news) today announced that its InfuSystem subsidiary has been approved by US Oncology Inc. (Nasdaq:USON - news) to provide infusion pump management services to US Oncology's network of more than 800 oncologists in 26 states. I-Flow anticipates that a majority of these oncologists will take advantage of InfuSystem's pump management services. I-Flow President and Chief Executive Officer Donald M. Earhart said: ``This new preferred provider relationship is a win-win situation for all parties. According to US Oncology, they supply cancer care for approximately 13 percent of the US cancer patient population. I-Flow now has an opportunity to join forces with US Oncology in serving the world's largest group of cancer patients. We are delighted to be associated with US Oncology and look forward to working closely with their healthcare professionals and patients.' ``InfuSystem's cost-effective infusion pump management service program will help US Oncology continue to provide high-quality cancer treatment, innovative medical technology and coordinated outpatient cancer care. By teaming with us, they can concentrate on maintaining the highest standards of patient care and continuity, while we focus on such critical concerns as equipment maintenance, pump protocols, pump obsolescence, and FDA and OSHA compliance requirements,' said InfuSystem President Steve Watkins. Noting that InfuSystem's unique nationwide pump management service is a market leader in ambulatory infusion services and is widely accepted by private practices and major healthcare institutions nationwide, Watkins added: ``Our ability to consistently provide excellent patient and provider service, at a cost-effective price, creates the opportunity for us to strategically align InfuSystem with a dynamic and respected organization such as US Oncology. With the addition of this relationship, the InfuSystem program now will be available at more than 60 percent of the oncology offices in the United States.' About US Oncology US Oncology is the nation's largest network of physicians, clinicians, nurses and administrators focused exclusively on oncology. US Oncology provides comprehensive cancer management services to more than 800 affiliated oncologists in 26 states. biz.yahoo.com